Skip to main content
Caplight Logo









GenoGra

GenoGra

Private
MilanHealthcare & Life Scienceshttps://genogra.com/

Last Round

Pre Seed

Feb 16, 2026

Total Funding Raised

$1.19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

GenoGra is a biotechnology company that develops a pangenomic software platform designed for faster and more accurate interpretation of genetic data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

pangenomic analysisgenome graphspangenome softwarebioinformatics platformnon-human genomicspangenome graphsgenome graph analysispopulation genomicsgenomic data analysisagricultural genomicslivestock genomicsgenomic analysis softwaregenomic data visualizationclinical genomicsprecision medicineindustrial microbiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenoGra Comparables

Compare GenoGra with similar companies based on industry and business-model similarity.

GenoGra comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Basepair Inc
72%
Velsera
71%
Illumina, Inc.
69%

GenoGra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 16, 2026

Key People

Founding team and executive leadership

Guido Walter Di Donato

Chief Executive Officer & Founder

Founding Team

Alessandro Vingione

Chief Operating Officer, Board Member

Executive Team

GenoGra Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Grew 63% QoQ, from 8 to 13 employees.

  • Apr 6, 2026

    Monthly visitors increased 191% MoM.

GenoGra Filings

Explore SEC and related filing metadata, where available.

GenoGra filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GenoGra's valuation, stock price, and market status.

Is GenoGra a public or private company?

GenoGra is a private company.

What is the current stock price of GenoGra?

GenoGra is a private company with no public stock price. No recent secondary market data is available.

How much is GenoGra worth (valuation)?

Valuation information for GenoGra is not publicly available.

Can I buy GenoGra stock?

GenoGra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GenoGra's last funding round?

GenoGra's most recent funding round was Pre Seed on February 16, 2026.

Who are the main investors in GenoGra?

Key investors in GenoGra include Maia Ventures.

Will GenoGra IPO soon?

No public IPO plans have been announced for GenoGra.

How can I track GenoGra secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenoGra's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMilan
Employee Range11
Year Founded2023
Last FundingFeb 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?